Applied Clinical Trials
Bristol-Myers Squibb’s cardiovascular development leader discusses the importance of diversifying clinical trials for better patient outcomes.
Christen Harm
Advertisement
Christen Harm is Pharmaceutical Executive's Associate Editor. Email her at [email protected]
Articles by Christen Harm
Advertisement
Latest Updated Articles
Creating Medicines ‘Appropriate for All’September 1st 2019
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Real-World Evidence Can No Longer Wait Until After Approval
2
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
3
ACT Brief: AI-Driven Patient Matching, Clinical Ops Tensions, and Oral COVID Prevention Approval
4
Three Tensions Transforming Clinical Operations Excellence
5